Loading markets…

Dianthus Therapeutics, Inc. (DNTH) forecast

Dianthus Therapeutics, Inc. (DNTH) forecast: price $76.34, trailing P/E -605.77, forward P/E 26.57. How to read the street's path.

$76.34Price
$4.27BMarket cap
-605.77P/E ?
26.57Forward P/E ?
0.00%Dividend yield ?

The live DNTH price is $76.34. Trailing P/E is -605.77 and forward P/E is 26.57. The forecast that matters is the earnings path those ratios imply, not a single target price.

A forward P/E below the trailing P/E means the consensus expects earnings to rise. The reverse means the market is looking at a peak. Neither is a schedule. Analyst targets are useful as a range of models. They are not a contract. Discounted cash flow is the long form: cash flows, a discount rate, and a terminal value you can argue with.

Use this page for the DNTH forecast URL. The prediction page next to it puts the same live inputs in the price-target framing. Both stay in sync with the quote on the main page.

Learn: Forward P/E · Analyst forecast · DCF

Full DNTH quote · Dividends · Price prediction · Academy

Questions

What is DNTH's forward P/E?

The latest forward P/E on Stocklytics is 26.57, against a trailing P/E of -605.77 and a price of $76.34.

Is the analyst target the forecast?

It is one forecast. The earnings estimate behind it is the part you can track. The target will be revised after the next report.